These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 26764121)
1. A prospective, open-label, multicenter study to assess the pharmacodynamics and safety of repeated use of 30 mg ulipristal acetate. Jesam C; Cochon L; Salvatierra AM; Williams A; Kapp N; Levy-Gompel D; Brache V Contraception; 2016 Apr; 93(4):310-316. PubMed ID: 26764121 [TBL] [Abstract][Full Text] [Related]
2. The effects on ovarian activity of ulipristal acetate when 'quickstarting' a combined oral contraceptive pill: a prospective, randomized, double-blind parallel-arm, placebo-controlled study. Cameron ST; Berger C; Michie L; Klipping C; Gemzell-Danielsson K Hum Reprod; 2015 Jul; 30(7):1566-72. PubMed ID: 25994664 [TBL] [Abstract][Full Text] [Related]
3. A prospective, randomized, pharmacodynamic study of quick-starting a desogestrel progestin-only pill following ulipristal acetate for emergency contraception. Brache V; Cochon L; Duijkers IJ; Levy DP; Kapp N; Monteil C; Abitbol JL; Klipping C Hum Reprod; 2015 Dec; 30(12):2785-93. PubMed ID: 26405263 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of ulipristal acetate for emergency contraception and its effect on the subsequent bleeding pattern when administered before or after ovulation. Li HW; Lo SS; Ng EH; Ho PC Hum Reprod; 2016 Jun; 31(6):1200-7. PubMed ID: 27052501 [TBL] [Abstract][Full Text] [Related]
6. Ulipristal acetate prevents ovulation more effectively than levonorgestrel: analysis of pooled data from three randomized trials of emergency contraception regimens. Brache V; Cochon L; Deniaud M; Croxatto HB Contraception; 2013 Nov; 88(5):611-8. PubMed ID: 23809278 [TBL] [Abstract][Full Text] [Related]
7. A randomized study on pharmacodynamic effects of vaginal rings delivering the progesterone receptor modulator ulipristal acetate: research for a novel estrogen-free, method of contraception. Huang Y; Jensen JT; Brache V; Cochon L; Williams A; Miranda MJ; Croxatto H; Kumar N; Sussman H; Hoskin E; Plagianos M; Roberts K; Merkatz R; Blithe D; Sitruk-Ware R Contraception; 2014 Dec; 90(6):565-74. PubMed ID: 25193534 [TBL] [Abstract][Full Text] [Related]
9. Ulipristal acetate: critical review about endometrial and ovulatory effects in emergency contraception. Mozzanega B; Gizzo S; Di Gangi S; Cosmi E; Nardelli GB Reprod Sci; 2014 Jun; 21(6):678-85. PubMed ID: 24440997 [TBL] [Abstract][Full Text] [Related]
10. Ulipristal acetate: review of the efficacy and safety of a newly approved agent for emergency contraception. Richardson AR; Maltz FN Clin Ther; 2012 Jan; 34(1):24-36. PubMed ID: 22154199 [TBL] [Abstract][Full Text] [Related]
11. Effects of ulipristal acetate on human embryo attachment and endometrial cell gene expression in an in vitro co-culture system. Berger C; Boggavarapu NR; Menezes J; Lalitkumar PG; Gemzell-Danielsson K Hum Reprod; 2015 Apr; 30(4):800-11. PubMed ID: 25740886 [TBL] [Abstract][Full Text] [Related]
12. The rationale for use of Ulipristal Acetate as first line in emergency contraception: biological and clinical evidence. Glasier A Gynecol Endocrinol; 2014 Oct; 30(10):688-90. PubMed ID: 25133564 [TBL] [Abstract][Full Text] [Related]
13. [Emergency contraception: efficacy difference between levonorgestrel and ulipristal acetate depending on the follicular size at the time of an unprotected sexual intercourse]. Jamin C Gynecol Obstet Fertil; 2015 Mar; 43(3):242-7. PubMed ID: 25703406 [TBL] [Abstract][Full Text] [Related]
14. Effect of ulipristal acetate and mifepristone at emergency contraception dose on the embryo-endometrial attachment using an in vitro human trophoblastic spheroid and endometrial cell co-culture model. Li HWR; Li YX; Li TT; Fan H; Ng EH; Yeung WS; Ho PC; Lee KF Hum Reprod; 2017 Dec; 32(12):2414-2422. PubMed ID: 29121217 [TBL] [Abstract][Full Text] [Related]
15. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Glasier AF; Cameron ST; Fine PM; Logan SJ; Casale W; Van Horn J; Sogor L; Blithe DL; Scherrer B; Mathe H; Jaspart A; Ulmann A; Gainer E Lancet; 2010 Feb; 375(9714):555-62. PubMed ID: 20116841 [TBL] [Abstract][Full Text] [Related]
16. Does ulipristal acetate emergency contraception (ella®) interfere with implantation? Li HWR; Resche-Rigon M; Bagchi IC; Gemzell-Danielsson K; Glasier A Contraception; 2019 Nov; 100(5):386-390. PubMed ID: 31351035 [TBL] [Abstract][Full Text] [Related]
17. The effects on ovarian activity of delaying versus immediately restarting combined oral contraception after missing three pills and taking ulipristal acetate 30 mg. Banh C; Rautenberg T; Duijkers I; Borenzstein P; Monteil C; Levy-Gompel D; Klipping C; Scherrer B; Glasier A Contraception; 2020 Sep; 102(3):145-151. PubMed ID: 32474062 [TBL] [Abstract][Full Text] [Related]
18. Emergency contraception -- mechanisms of action. Gemzell-Danielsson K; Berger C; P G L L Contraception; 2013 Mar; 87(3):300-8. PubMed ID: 23114735 [TBL] [Abstract][Full Text] [Related]
19. Combined oral contraceptive interference with the ability of ulipristal acetate to delay ovulation: A prospective cohort study. Edelman AB; Jensen JT; McCrimmon S; Messerle-Forbes M; O'Donnell A; Hennebold JD Contraception; 2018 Dec; 98(6):463-466. PubMed ID: 30118684 [TBL] [Abstract][Full Text] [Related]
20. Effects of a novel estrogen-free, progesterone receptor modulator contraceptive vaginal ring on inhibition of ovulation, bleeding patterns and endometrium in normal women. Brache V; Sitruk-Ware R; Williams A; Blithe D; Croxatto H; Kumar N; Kumar S; Tsong YY; Sivin I; Nath A; Sussman H; Cochon L; Miranda MJ; Reyes V; Faundes A; Mishell D Contraception; 2012 May; 85(5):480-8. PubMed ID: 22176795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]